nach oben

European Child & Adolescent Psychiatry

Erschienen in:

21.05.2016 | Original Contribution

Defining cognitive-behavior therapy response and remission in pediatric OCD: a signal detection analysis of the Children’s Yale-Brown Obsessive Compulsive Scale

verfasst von: Gudmundur Skarphedinsson, Alessandro S. De Nadai, Eric A. Storch, Adam B. Lewin, Tord Ivarsson

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

The objective of the study was to examine the optimal Children’s Yale-Brown Obsessive–Compulsive Scale (CY-BOCS) percent reduction and raw cutoffs for predicting cognitive-behavioral treatment (CBT) response among children and adolescents with obsessive–compulsive disorder (OCD). The sample consisted of children and adolescents with OCD (N = 241) participating in the first step of the Nordic long-term OCD treatment study and receiving 14 weekly sessions of CBT in the form of exposure and response prevention. Evaluations were conducted pre- and post-treatment, included the CY-BOCS, Clinical Global Impressions—severity/improvement. The results showed that the most efficient CY-BOCS cutoffs were 35 % reduction for treatment response, 55 % reduction for remission, and a post-treatment CY-BOCS raw total score of 11 for treatment remission. Overall, our results diverge from previous research on pediatric OCD with more conservative cutoffs (higher cutoff reduction for response and remission, and lower raw score for remission). Further research on optimal cutoffs is needed.

Rasmussen SA, Eisen JL (1992) The epidemiology and clinical features of obsessive compulsive disorder. Psychiatr Clin North Am 15:743–758PubMed

Ruscio AM, Stein DJ, Chiu WT, Kessler RC (2010) The epidemiology of obsessive–compulsive disorder in the national comorbidity survey replication. Mol Psychiatry 15:53–63CrossRefPubMed

Stewart SE, Geller DA, Jenike M, Pauls D, Shaw D, Mullin B, Faraone SV (2004) Long-term outcome of pediatric obsessive–compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiat Scand 110:4–13CrossRefPubMed

Flament MF, Whitaker A, Rapoport JL, Davies M, Berg CZ, Kalikow K, Sceery W, Shaffer D (1988) Obsessive compulsive disorder in adolescence: an epidemiological study. J Am Acad Child Adolesc Psychiatry 27:764–771CrossRefPubMed

Valleni-Basile LA, Garrison CZ, Jackson KL, Waller JL, McKeown RE, Addy CL, Cuffe SP (1994) Frequency of obsessive–compulsive disorder in a community sample of young adolescents. J Am Acad Child Adolesc Psychiatry 33:782–791 (Erratum appears in J Am Acad Child Adolesc Psychiatry. 1995 Feb;34(2):128–129; PMID: 7896644) CrossRefPubMed

Rapoport JL, Inoff-Germain G, Weissman MM, Greenwald S, Narrow WE, Jensen PS, Lahey BB, Canino G (2000) Childhood obsessive–compulsive disorder in the NIMH MECA study: parent versus child identification of cases. Methods for the epidemiology of child and adolescent mental disorders. J Anxiety Disord 14:535–548CrossRefPubMed

Skarphedinsson G, Hanssen-Bauer K, Kornor H, Heiervang ER, Landro NI, Axelsdottir B, Biedilae S, Ivarsson T (2015) Standard individual cognitive behaviour therapy for paediatric obsessive–compulsive disorder: a systematic review of effect estimates across comparisons. Nord J Psychiatry 69:81–92CrossRefPubMed

Ivarsson T, Skarphedinsson G, Kornor H, Axelsdottir B, Biedilae S, Heyman I, Asbahr F, Thomsen PH, Fineberg N, March J (2015) The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: views based on a systematic review and meta-analysis. Psychiatry Res 227:93–103CrossRefPubMed

Geller D, March J (2012) Practice parameter for the assessment and treatment of children and adolescents with obsessive–compulsive disorder. J Am Acad Child Adolesc Psychiatry 51:98–113CrossRef

10.

NICE (2005) Obsessive compulsive disorder (OCD) and body dysmorphic disorder (BDD). In: Excellence NIfHaC (ed) National Institute for Health and Clinical Excellence, London

11.

Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, Cicchetti D, Leckman JF (1997) Children’s Yale-Brown obsessive compulsive scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 36:844–852CrossRefPubMed

12.

Lewin A, Piacentini J (2010) Evidence-based assessment of child obsessive compulsive disorder: recommendations for clinical practice and treatment research. Child Youth Care Forum 39:73–89CrossRefPubMedPubMedCentral

13.

Storch EA, Murphy TK, Bagner DM, Johns NB, Baumeister AL, Goodman WK, Geffken GR (2006) Reliability and validity of the child behavior checklist obsessive–compulsive scale. J Anxiety Disord 20:473–485CrossRefPubMed

14.

Lewin AB, Piacentini J, De Nadai AS, Jones AM, Peris TS, Geffken GR, Geller DA, Nadeau JM, Murphy TK, Storch EA (2014) Defining clinical severity in pediatric obsessive–compulsive disorder. Psychol Assess 26:679–684CrossRefPubMed

15.

Busner J, Targum SD (2007) The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry 4:28–37PubMedPubMedCentral

16.

Garvey MA, Perlmutter SJ, Allen AJ, Hamburger S, Lougee L, Leonard HL, Witowski ME, Dubbert B, Swedo SE (1999) A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 45:1564–1571CrossRefPubMed

17.

Tolin DF, Abramowitz JS, Diefenbach GJ (2005) Defining response in clinical trials for obsessive–compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale. J Clin Psychiatry 66:1549–1557CrossRefPubMed

18.

Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM (1991) Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48:851–855CrossRefPubMed

19.

Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver TJ, Murphy DL (1990) Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive–compulsive disorder. Behavioral and biological results. Arch Gen Psychiatry 47:926–932CrossRefPubMed

20.

Cottraux J, Note I, Yao SN, Lafont S, Note B, Mollard E, Bouvard M, Sauteraud A, Bourgeois M, Dartigues JF (2001) A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder. Psychother Psychosom 70:288–297CrossRefPubMed

21.

Simpson HB, Gorfinkle KS, Liebowitz MR (1999) Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive–compulsive disorder: an open trial. J Clin Psychiatry 60:584–590CrossRefPubMed

22.

Sookman D, Steketee G (2007) Directions in specialized cognitive behavior therapy for resistant obsessive–compulsive disorder: theory and practice of two approaches. Cognit Behav Pract 14:1–17CrossRef

23.

Wagner KD, Cook EH, Chung H, Messig M (2003) Remission status after long-term sertraline treatment of pediatric obsessive–compulsive disorder. J Child Adoles Psychopharmacol 13(Suppl 1):S53–S60CrossRef

24.

Piacentini J, Bergman RL, Chang S, Langley A, Peris T, Wood JJ, McCracken J (2011) Controlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training for child obsessive–compulsive disorder. J Am Acad Child Adolesc Psychiatry 50:1149–1161CrossRefPubMedPubMedCentral

25.

POTS Study Team (2004) Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive–compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 292:1969–1976CrossRef

26.

Torp NC, Dahl K, Skarphedinsson G, Thomsen P, Valderhaug R, Weidle B, Melin K, Hybel K, Nissen JB, Lenhard F, Wentzel-Larsen T, Franklin M, Ivarsson T (2015) Effectiveness of cognitive behavior treatment for pediatric obsessive–compulsive disorder: acute outcomes from the Nordic long-term OCD treatment study (NordLOTS). Behav Res Ther 64:15–23CrossRefPubMed

27.

Turner CM, Mataix-Cols D, Lovell K, Krebs G, Lang K, Byford S, Heyman I (2014) Telephone cognitive-behavioral therapy for adolescents with obsessive–compulsive disorder: a randomized controlled non-inferiority trial. J Am Acad Child Adolesc Psychiatry 53:1298–1307.e1292CrossRefPubMedPubMedCentral

28.

Caporino NE, Brodman DM, Kendall PC, Albano AM, Sherrill J, Piacentini J, Sakolsky D, Birmaher B, Compton SN, Ginsburg G, Rynn M, McCracken J, Gosch E, Keeton C, March J, Walkup JT (2013) Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale. J Am Acad Child Adolesc Psychiatry 52:57–67CrossRefPubMed

29.

Storch EA, Lewin AB, De Nadai AS, Murphy TK (2010) Defining treatment response and remission in obsessive–compulsive disorder: a signal detection analysis of the children’s Yale-Brown obsessive compulsive scale. J Am Acad Child Adolesc Psychiatry 49:708–717PubMed

30.

Lewin AB, De Nadai AS, Park J, Goodman WK, Murphy TK, Storch EA (2011) Refining clinical judgment of treatment outcome in obsessive–compulsive disorder. Psychiatry Res 185:394–401CrossRefPubMed

31.

Swets JA, Pickett RM (1982) Evaluation of Diagnostic Systems: Methods from signal detection theory. Academic Press, New York

32.

Thomsen PH, Torp NC, Dahl K, Christensen K, Englyst I, Melin KH, Nissen JB, Hybel KA, Valderhaug R, Weidle B, Skarphedinsson G, von Bahr PL, Ivarsson T (2013) The Nordic long-term OCD treatment study (NordLOTS): rationale, design, and methods. Child Adolesc Psychiatry Mental Health 7:41CrossRef

33.

Skarphedinsson G, Weidle B, Thomsen PH, Dahl K, Torp NC, Nissen JB, Melin KH, Hybel K, Valderhaug R, Wentzel-Larsen T, Compton SN, Ivarsson T (2015) Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive–compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial. Eur Child Adolesc Psychiatry 24:591–602CrossRefPubMed

34.

American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition (Text Revision). American Psychiatric Association, Washington, DCCrossRef

35.

Torp NC, Dahl K, Skarphedinsson G, Thomsen PH, Valderhaug R, Weidle B, Hybel K, Compton S, Ivarsson T (2015) Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive–compulsive disorder. J Am Acad Child Adolesc Psychiatry 54:200–207CrossRefPubMed

36.

Kaufman J, Birmaher B, Brent D, Rao U et al (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980–988CrossRefPubMed

37.

Lauth B, Arnkelsson GB, Magnusson P, Skarphedinsson G, Ferrari P, Petursson H (2010) Validity of K-SADS-PL (schedule for affective disorders and schizophrenia for school-age children-present and lifetime version) depression diagnoses in an adolescent clinical population. Nord J Psychiatry 64:409–420CrossRefPubMed

38.

Lauth B, Magnusson P, Ferrari P, Petursson H (2008) An Icelandic version of the kiddie-SADS-PL: translation, cross-cultural adaptation and inter-rater reliability. Nord J Psychiatry 62:379–385CrossRefPubMed

39.

Valderhaug R, Larsson B, Gotestam KG, Piacentini J (2007) An open clinical trial of cognitive-behaviour therapy in children and adolescents with obsessive–compulsive disorder administered in regular outpatient clinics. Behav Res Ther 45:577–589CrossRefPubMed

40.

Freeman JB, Garcia AM, Coyne L, Ale C, Przeworski A, Himle M, Compton S, Leonard HL (2008) Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach. J Am Acad Child Adolesc Psychiatry 47:593–602CrossRefPubMedPubMedCentral

41.

Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI (1997) Children’s Yale-Brown obsessive compulsive scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 36:844–852CrossRefPubMed

42.

Storch EA, Murphy TK, Geffken GR, Soto O, Sajid M, Allen P, Roberti JW, Killiany EM, Goodman WK (2004) Psychometric evaluation of the children’s Yale-Brown obsessive–compulsive scale. Psychiatry Res 129:91–98CrossRefPubMed

43.

Gallant J, Storch EA, Merlo LJ, Ricketts ED, Geffken GR, Goodman WK, Murphy TK (2008) Convergent and discriminant validity of the children’s Yale-Brown obsessive compulsive scale-symptom checklist. J Anxiety Disord 22:1369–1376CrossRefPubMed

44.

Guy W (1976) ECDEU assessment manual for psychopharmacology. Government Printing Office, Washington

45.

Kraemer H, Periyakoil VS, Noda A (2002) Kappa coefficients in medical research. Stat Med 21:2109–2129CrossRef

46.

Kraemer H (1992) Evaluating medical tests: objective and quantitative guidelines. Sage Publications, Thousand Oaks

47.

Pallanti S, Hollander E, Bienstock C, Koran L, Leckman J, Marazziti D, Pato M, Stein D, Zohar J, International Treatment Refractory OCDC (2002) Treatment non-response in OCD: methodological issues and operational definitions. Int J Neuropsychopharmacol 5:181–191CrossRefPubMed

48.

Leucht S, Davis JM, Engel RR, Kane JM, Wagenpfeil S (2007) Defining ‘response’ in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs. Neuropsychopharmacology 32:1903–1910CrossRefPubMed

49.

Mataix-Cols D, de la Cruz LF, Nordsletten AE, Lenhard F, Isomura K, Simpson HB (2016) Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive–compulsive disorder. World Psychiatry 15:80–81CrossRefPubMedPubMedCentral

50.

Farris SG, McLean CP, Van Meter PE, Simpson HB, Foa EB (2013) Treatment response, symptom remission, and wellness in obsessive–compulsive disorder. J Clin Psychiatry 74:685–690CrossRefPubMedPubMedCentral

51.

Frank E, Kupfer DJ, Wagner EF, McEachran AB, Cornes C (1991) Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression: contributing factors. Arch Gen Psychiatry 48:1053–1059 [Erratum appears in Arch Gen Psychiatry 1992 May; 49(5):401] CrossRefPubMed

52.

Kennard BD, Emslie GJ, Mayes TL, Nakonezny PA, Jones JM, Foxwell AA, King J (2014) Sequential treatment with fluoxetine and relapse–prevention CBT to improve outcomes in pediatric depression. Am J Psychiatry 171:1083–1090CrossRefPubMedPubMedCentral

53.

Franklin ME, Sapyta J, Freeman JB, Khanna M, Compton S, Almirall D, Moore P, Choate-Summers M, Garcia A, Edson AL, Foa EB, March JS (2011) Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive–compulsive disorder: the pediatric OCD treatment study II (POTS II) randomized controlled trial. J Am Med Assoc. 306:1224–1232CrossRef

54.

Eisen JL, Goodman WK, Keller MB, Warshaw MG, DeMarco LM, Luce DD, Rasmussen SA (1999) Patterns of remission and relapse in obsessive–compulsive disorder: a 2-year prospective study. J Clin Psychiatry 60:346–351 (quiz 352) CrossRefPubMed

55.

Leckman JF, Sholomskas D, Thompson D, Belanger A, Weissman MM (1982) Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry 39:879–883CrossRefPubMed

56.

Højgaard DRMA, Mortensen E, Ivarsson T, Valderhaug R, Hybel K, Skarphedinsson G, Dahl K, Weidle B, Torp N, Grados M (2015) Child and adolescent OCD symptom patterns: a factor analytic study. In: 16th International ESCAP congress, Madrid, Spain, pp S187–S187

Titel: Defining cognitive-behavior therapy response and remission in pediatric OCD: a signal detection analysis of the Children’s Yale-Brown Obsessive Compulsive Scale
verfasst von: Gudmundur Skarphedinsson
Alessandro S. De Nadai
Eric A. Storch
Adam B. Lewin
Tord Ivarsson
Publikationsdatum: 21.05.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: European Child & Adolescent Psychiatry / Ausgabe 1/2017
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI: https://doi.org/10.1007/s00787-016-0863-0

Neu im Fachgebiet Psychiatrie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Defining cognitive-behavior therapy response and remission in pediatric OCD: a signal detection analysis of the Children’s Yale-Brown Obsessive Compulsive Scale

Abstract

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Psychiatrie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

An initial study of family accommodation in children and adolescents with chronic tic disorders

Preschool hyperactivity specifically elevates long-term mental health risks more strongly in males than females: a prospective longitudinal study through to young adulthood

“Did I bring it on myself?” An exploratory study of the beliefs that adolescents referred to mental health services have about the causes of their depression

Psychosocial risk factors underlie the link between attention deficit hyperactivity symptoms and overweight at school entry

The need for evidence-based intake, progress, and outcomes assessment

The prospective usefulness of callous–unemotional traits and conduct disorder in predicting treatment engagement among detained girls

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Psychiatrie